Depositions of key executives in DePuy Orthopedics are scheduled to take place over the next three months in the federal DePuy ASR hip recall lawsuits. In August 2010, DePuy Orthopedics issued a worldwide ASR hip recall after receiving data of high failure rates of its ASR line of hip replacement implants. Thousands have filed DePuy ASR lawsuits seeking compensation for their injuries. We hope the depositions of these high ranking company executives will reveal more about the circumstances surrounding the DePuy ASR hip recall. At the depositions, the executives have been asked to produce documents, presentations, testimonies, oral proposals and other materials relevant to the ASR hip recall.

Eight depositions are scheduled in the federal DePuy ASR litigation, including David Floyd, the president of DePuy Orthopedics at the time of the ASR hip recall, who resigned in March 2011, and Andrew Ekdahl, who was named president of the Johnson & Johnson subsidiary in June 2011.

According to a New York Times investigation earlier this year, Floyd knew of the ASR hip implants’ deficits long before the recall. As reported by the Times, Pamela Plouhar, a vice president of DePuy Orthopaedics emailed three DePuy executives including Floyd in August 2009 to inform them that the U.S. Food and Drug Administration (“FDA”) refused to approve one version of the recalled ASR hip implants. Plouhar wrote: “The team’s concern is that given the revision rate in the ASR group that we will still not be able to demonstrate non-inferiority, with additional downside risk.” The FDA reviewed company studies and clinical data and found that the device had unacceptably high failure rates. Despite this early knowledge of DePuy ASR hip implant problems, it took a year for the company to finally issue the ASR hip recall that affected thousands worldwide.

In addition to David Floyd and Andrew Ekdahl, the other company executives to be deposed include:

  • Matt Reimink, Manager, Development, DePuy Orthopaedics, Inc.;
  • Mary Stewart, Research & Development, DePuy International Ltd.;
  • Paul Voorhorst, Director, Biostatistics & Data Management, DePuy Orthopaedics, Inc.;
  • Paul Kurring, Director of Marketing, International Hip Business, DePuy Int’l. Ltd.;
  • Rodrigo Diaz, Manager Clinical Research, DePuy Orthopaedics, Inc.; and
  • Tom Camino, WW Hip Development Director, DePuy Orthopaedics Inc.

We’re eager to see such progress in the DePuy ASR hip recall lawsuits. If you were affected by the ASR hip recall and suffered from complications or had to undergo revision surgery to replace your defective hip, contact a hip recall lawyer at our firm right away. You may be entitled to compensation for your medical expenses, pain and suffering, lost wages and other injuries. We are currently offering free and confidential case reviews. Speak to a lawyer today by calling (877) 779-1414.

Published September 11, 2012 by